Darielys Santana-Mederos
Finlay Institute(CU)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Pneumonia and Respiratory Infections, COVID-19 Clinical Research Studies, Vaccine Coverage and Hesitancy, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies(2021)88 cited
- → Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction(2019)69 cited
- → Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines(2021)66 cited
- → Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates(2018)53 cited
- → Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials(2022)38 cited
- → Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults(2022)30 cited
- → A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles(2021)29 cited
- → Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children(2022)21 cited
- → Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine Candidates(2020)20 cited
- → Design and Biological Assembly of Polyester Beads Displaying Pneumococcal Antigens as Particulate Vaccine(2018)17 cited